Inflammation & Oxidative Stress Panel

Advanced inflammatory and oxidative stress marker panel measuring CRP, homocysteine, IL-6, TNF-alpha, and urinary oxidative stress markers. Identifies chronic low-grade inflammation driving accelerated ageing and disease risk.

Chronic low-grade inflammation — sometimes called 'inflammaging' — is now recognised as one of the primary drivers of accelerated biological ageing and the root cause linking most of the major chronic diseases: cardiovascular disease, type 2 diabetes, neurodegenerative conditions, cancer, and autoimmune disorders. Unlike acute inflammation, this smouldering process produces no obvious symptoms, often remaining undetected for years while silently damaging tissues and shortening healthspan. Asia Longevity's Inflammation and Oxidative Stress Panel is designed to detect and quantify this hidden burden, providing an early warning system that allows targeted intervention well before clinical disease manifests. The panel measures a comprehensive range of inflammatory biomarkers including high-sensitivity C-reactive protein (hsCRP) — a sensitive marker of systemic inflammation — interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-α), and interleukin-1 beta. Homocysteine is assessed as both an inflammatory and cardiovascular risk marker, with elevated levels linked to accelerated arterial disease, cognitive decline, and Alzheimer's risk. Oxidative stress is quantified via urinary 8-hydroxydeoxyguanosine (8-OHdG), a marker of DNA oxidative damage, alongside lipid peroxidation markers. Together, these measurements indicate whether cellular antioxidant defences are keeping pace with free radical production — a balance that is central to healthy cellular ageing. Results are reviewed by a physician who identifies the likely drivers of elevated inflammation (diet, stress, sleep disruption, gut dysbiosis, hormonal imbalance, environmental toxins) and designs a targeted anti-inflammatory intervention plan. This may include dietary modification, targeted supplementation, IV antioxidant therapy, or referral for further specialist investigation.